NCT02682316

Brief Summary

The purpose of this study is to compare any good and bad effects of using the Prevena Incision Management System to using the usual standard dry gauze approach. The Prevena Incision Management System is a type of Negative Pressure Wound Therapy (NPWT). NPWT is a portable vacuum device made of a sponge-like foam that is applied over your incision to help draw fluid and debris out after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
583

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Feb 2016

Longer than P75 for phase_3

Geographic Reach
1 country

10 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2016

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

February 4, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 15, 2016

Completed
7.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 25, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 25, 2024

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

March 18, 2025

Completed
Last Updated

March 18, 2025

Status Verified

January 1, 2024

Enrollment Period

8 years

First QC Date

February 4, 2016

Results QC Date

January 24, 2025

Last Update Submit

March 10, 2025

Conditions

Keywords

undergoing laparotomy15-309

Outcome Measures

Primary Outcomes (1)

  • Number of Post-op Wound Complications

    Incidence of inpatient post-operative wound complications will be documented through the use of an inpatient data collection sheet. Incidence of outpatient post-operative wound complication will be documented through the use of an outpatient data collection sheet that will be completed by a provider at the time of the routine post-operative follow-up visit, which will occur at 30 days +/- 5 days after the day of surgery as well as through ongoing documentation of events as elicited through the institution's standard reporting system to collect information on enrolled patients.

    30 days +/- 5 days after surgery

Study Arms (2)

usual standard dry gauze used for wound management

ACTIVE COMPARATOR

Patients who are randomized to the standard dry gauze arm will have the standard dry gauze placed at time of wound closure. Their dressing will be removed on post-operative day 2 as per routine departmental practice.

Other: dry gauze

Prevena Negative Pressure Wound Therapy System (NPWT)

EXPERIMENTAL

Patients who are randomized to the Prevena Therapy System arm will have the Prevena Incision Management System device placed at time of wound closure. The device will be removed on day of discharge from the hospital or post-operative day 7, whichever comes first.

Device: The Prevena Incision Management System

Interventions

usual standard dry gauze used for wound management
Prevena Negative Pressure Wound Therapy System (NPWT)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Criteria for Eligibility Prior to Surgery:
  • Women of any BMI undergoing a laparotomy procedure for a presumed gynecologic malignancy, or morbidly obese (BMI ≥ 40) women undergoing a laparotomy for any indication
  • or women who are morbidly obese (BMI\>40) undergoing laparotomy for any indication
  • Age ≥ 18
  • Criteria for Eligibility During Surgery:
  • Women of any BMI undergoing a laparotomy procedure for a presumed gynecologic malignancy, or morbidly obese (BMI ≥ 40) women undergoing a laparotomy for any indication
  • or women who are morbidly obese (BMI\>40) undergoing laparotomy for any indication
  • Age ≥ 18

You may not qualify if:

  • Women undergoing panniculectomy at the time of laparotomy
  • Women with sensitivity to silver
  • Women with laparotomy incisions left open due to case classification as "contaminated" or "dirty"
  • Women with laparotomy incisions unable to be closed primarily due to tissue or fascial damage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

Hartford Healthcare Cancer Institute @ Hartford Hospital

Hartford, Connecticut, 06102, United States

Location

Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up only)

Basking Ridge, New Jersey, 07920, United States

Location

Memorial Sloan Kettering Monmouth (Consent and Follow-Up only)

Middletown, New Jersey, 07748, United States

Location

Memorial Sloan Kettering Bergen (Consent and Follow-Up only)

Montvale, New Jersey, 07645, United States

Location

Memorial Sloan Kettering Commack (Consent and Follow-Up only)

Commack, New York, 11725, United States

Location

Memorial Sloan Kettering Westchester (Consent and Follow-Up only)

Harrison, New York, 10604, United States

Location

Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States

Location

Memorial Sloan Kettering Rockville (Consent and Follow-Up only)

Rockville Centre, New York, 11570, United States

Location

Memorial Sloan Kettering Nassau (Consent and Follow-Up only)

Uniondale, New York, 11553, United States

Location

Lehigh Valley Health Network

Allentown, Pennsylvania, 18103, United States

Location

Related Publications (1)

  • Leitao MM Jr, Zhou QC, Schiavone MB, Cowan RA, Smith ES, Iasonos A, Veith M, Rafizadeh M, Curran K, Ramesh B, Chang K, Chi DS, Sonoda Y, Brown AK, Cosin JA, Abu-Rustum NR, Martino MA, Mueller JJ, Long Roche K, Jewell EL, Broach V, Lambrou NC, Diaz JP, Zivanovic O. Prophylactic Negative Pressure Wound Therapy After Laparotomy for Gynecologic Surgery: A Randomized Controlled Trial. Obstet Gynecol. 2021 Feb 1;137(2):334-341. doi: 10.1097/AOG.0000000000004243.

Related Links

Results Point of Contact

Title
Dr. Mario Leitao, MD
Organization
Memorial Sloan Kettering Cancer Center

Study Officials

  • Mario Leitao, MD

    Memorial Sloan Kettering Cancer Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 4, 2016

First Posted

February 15, 2016

Study Start

February 1, 2016

Primary Completion

January 25, 2024

Study Completion

January 25, 2024

Last Updated

March 18, 2025

Results First Posted

March 18, 2025

Record last verified: 2024-01

Locations